QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
NASDAQ:AFIB

Acutus Medical - AFIB Stock Forecast, Price & News

$0.75
-0.04 (-5.09%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.74
$0.79
50-Day Range
$0.75
$1.87
52-Week Range
$0.48
$2.15
Volume
140,236 shs
Average Volume
180,030 shs
Market Capitalization
$21.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

Acutus Medical MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
168.4% Upside
$2.00 Price Target
Short Interest
Healthy
2.10% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.29mentions of Acutus Medical in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.39) to ($1.68) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.12 out of 5 stars

Medical Sector

335th out of 995 stocks

Surgical & Medical Instruments Industry

29th out of 103 stocks


AFIB stock logo

About Acutus Medical (NASDAQ:AFIB) Stock

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

AFIB Stock News Headlines

BTIG Sticks to Its Buy Rating for Acutus Medical (AFIB)
BTIG Sticks to Their Buy Rating for Acutus Medical (AFIB)
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
Acutus Medical's Earnings: A Preview
Medical Moment: Amulet for AFib
BTIG Keeps Their Buy Rating on Acutus Medical (AFIB)
See More Headlines
Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

AFIB Company Calendar

Last Earnings
11/11/2021
Today
3/27/2023
Next Earnings (Estimated)
5/11/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AFIB
Employees
291
Year Founded
2011

Price Target and Rating

Average Stock Price Forecast
$2.00
High Stock Price Forecast
$2.50
Low Stock Price Forecast
$1.50
Forecasted Upside/Downside
+168.4%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-39,620,000.00
Net Margins
-242.11%
Pretax Margin
-545.51%

Debt

Sales & Book Value

Annual Sales
$16.36 million
Book Value
$3.78 per share

Miscellaneous

Free Float
21,538,000
Market Cap
$21.20 million
Optionable
Not Optionable
Beta
0.95

Social Links


Key Executives

  • Mr. R. Scott Huennekens CPA (Age 58)
    M.B.A., Exec. Chairman
    Comp: $121k
  • Mr. David Harrison Roman (Age 40)
    CEO, Pres & Director
    Comp: $679.4k
  • Mr. Vincent J. Burgess (Age 57)
    Consultant
    Comp: $583.5k
  • Mr. Takeo Mukai
    VP of Fin. & Accounting and Interim CFO
  • Dr. Graydon E. Beatty (Age 65)
    Chief Technology Officer
  • Dr. Derrick Chou Ph.D.
    Chief Technology Officer
  • Mr. Tom Sohn (Age 47)
    Sr. VP, Gen. Counsel & Sec.
  • Mr. Shibaji Shome Ph.D.
    VP of Marketing
  • Mr. Charlie Piscitello (Age 59)
    Sr. VP & Chief People Officer
  • Mr. Gary W. Doherty (Age 56)
    Sr. VP of Fin.













AFIB Stock - Frequently Asked Questions

Should I buy or sell Acutus Medical stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Acutus Medical in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" AFIB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AFIB, but not buy additional shares or sell existing shares.
View AFIB analyst ratings
or view top-rated stocks.

What is Acutus Medical's stock price forecast for 2023?

3 Wall Street research analysts have issued 1 year target prices for Acutus Medical's stock. Their AFIB share price forecasts range from $1.50 to $2.50. On average, they anticipate the company's stock price to reach $2.00 in the next year. This suggests a possible upside of 168.4% from the stock's current price.
View analysts price targets for AFIB
or view top-rated stocks among Wall Street analysts.

How have AFIB shares performed in 2023?

Acutus Medical's stock was trading at $1.15 at the beginning of 2023. Since then, AFIB stock has decreased by 35.2% and is now trading at $0.7452.
View the best growth stocks for 2023 here
.

Are investors shorting Acutus Medical?

Acutus Medical saw a increase in short interest in March. As of March 15th, there was short interest totaling 393,800 shares, an increase of 13.8% from the February 28th total of 346,100 shares. Based on an average daily trading volume, of 186,700 shares, the short-interest ratio is currently 2.1 days. Currently, 2.1% of the shares of the stock are sold short.
View Acutus Medical's Short Interest
.

When is Acutus Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023.
View our AFIB earnings forecast
.

How were Acutus Medical's earnings last quarter?

Acutus Medical, Inc. (NASDAQ:AFIB) posted its earnings results on Thursday, November, 11th. The company reported ($0.94) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.92) by $0.02. The company had revenue of $4.60 million for the quarter, compared to analysts' expectations of $6.02 million. Acutus Medical had a negative trailing twelve-month return on equity of 45.94% and a negative net margin of 242.11%. During the same period in the previous year, the company posted ($1.18) earnings per share.

What guidance has Acutus Medical issued on next quarter's earnings?

Acutus Medical issued an update on its FY 2023 earnings guidance on Thursday, March, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $18.00 million-$21.00 million, compared to the consensus revenue estimate of $20.46 million.

What other stocks do shareholders of Acutus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acutus Medical investors own include Oak Street Health (OSH), Alibaba Group (BABA), Checkmate Pharmaceuticals (CMPI), Salesforce (CRM), Walt Disney (DIS), DocuSign (DOCU), Marvell Technology (MRVL), NVIDIA (NVDA), Tesla (TSLA) and Twilio (TWLO).

When did Acutus Medical IPO?

(AFIB) raised $126 million in an IPO on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Acutus Medical's stock symbol?

Acutus Medical trades on the NASDAQ under the ticker symbol "AFIB."

Who are Acutus Medical's major shareholders?

Acutus Medical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (1.07%), Kamunting Street Capital Management L.P. (0.91%), Millennium Management LLC (0.63%), Morgan Stanley (0.45%), Nicolet Advisory Services LLC (0.10%) and Belvedere Trading LLC (0.00%). Insiders that own company stock include James F Hinrichs, Orbimed Advisors Llc and R Scott Huennekens.
View institutional ownership trends
.

How do I buy shares of Acutus Medical?

Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Acutus Medical's stock price today?

One share of AFIB stock can currently be purchased for approximately $0.75.

How much money does Acutus Medical make?

Acutus Medical (NASDAQ:AFIB) has a market capitalization of $21.20 million and generates $16.36 million in revenue each year. The company earns $-39,620,000.00 in net income (profit) each year or ($1.57) on an earnings per share basis.

How many employees does Acutus Medical have?

The company employs 291 workers across the globe.

Does Acutus Medical have any subsidiaries?
The following companies are subsidiares of Acutus Medical: Acutus Medical N.V..
Read More
How can I contact Acutus Medical?

Acutus Medical's mailing address is 2210 FARADAY AVE SUITE 100, CARLSBAD CA, 92008. The official website for the company is www.acutusmedical.com. The company can be reached via phone at 442-232-6080, via email at investors@acutusmedical.com, or via fax at 442-232-6081.

This page (NASDAQ:AFIB) was last updated on 3/27/2023 by MarketBeat.com Staff